A client calls the clinic to report exposure to poison ivy and an itchy rash that is not helped with over-the-counter antihistamines. What response by the nurse is most appropriate?

Choice A rationale Poison ivy rash is a type IV delayed-type hypersensitivity reaction caused by contact with the oily resin urushiol, which triggers a T-cell mediated inflammatory response. Since it is a cellular, not histamine-mediated, reaction, over-the-counter antihistamines are generally ineffective in controlling the associated severe itching, which explains the client's current lack of relief. Choice B rationale While different antihistamine types and strengths exist, their mechanism involves blocking H1 histamine receptors, which primarily targets acute allergic reactions (type I hypersensitivity). Because the poison ivy rash is a T-cell-mediated response, increasing the dose or changing the strength of an antihistamine will not effectively suppress the underlying inflammatory process or provide significant relief. Choice C rationale A persistent, intensely itchy rash not relieved by typical management warrants an assessment, but a poison ivy rash is often managed with potent topical corticosteroids or short courses of oral corticosteroids. Stating a need to be seen right away is slightly premature and over-urgent before determining the severity and discussing initial treatment options for the common presentation. Choice D rationale Intravenous (IV) steroids are reserved for severe, life-threatening allergic or inflammatory conditions, such as anaphylaxis or extensive, debilitating poison ivy exposure covering a large body surface area, potentially involving mucous membranes. Oral corticosteroids are the standard systemic treatment for severe poison ivy, making IV steroids usually unnecessary and too aggressive. —.